Hearing Loss Disease Portal


 
Switch to table view
Most Common: Hearing Loss (D034381), Deafness (D003638), Sensorineural HL (D006319), Waardenburg Syndrome, Usher Syndromes
Disease Browser
Parent Node:
expand
Anemia, Hemolytic, Congenital (D000745)
Parent Node:
expand
Hemoglobinopathies (D006453)
..Starting node
..expand
Anemia, Sickle Cell (D000755)

       Child Nodes:
........expandAcute Chest Syndrome (D056586)
........expandHemoglobin SC Disease (D006450)
........expandSickle Cell Trait (D012805)



 Sister Nodes: 
..expandAnemia, Sickle Cell (D000755) Child3
..expandHemoglobin C Disease (D006445) Child1
..expandThalassemia (D013789) Child16
   

Human Disease MESH is developed by UMLS.
Further data from MedGen, OMIM, CTD
Term ID:647
Name:Anemia, Sickle Cell
Definition:A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
Alternative IDs:OMIM:603903
ParentIDs:MESH:D000745|MESH:D006453
TreeNumbers:C15.378.071.141.150.150 |C15.378.420.155 |C16.320.070.150 |C16.320.365.155
Synonyms:Anemias, Sickle Cell |Cell Disease, Sickle |Cell Diseases, Sickle |Cell Disorder, Sickle |Cell Disorders, Sickle |Disease, Hemoglobin S |HbS Disease |Hemoglobin S Disease |Hemoglobin S Diseases |Sickle Cell Anemia |Sickle Cell Anemias |Sickle Cell Disease |Sickle Ce
Slim Mappings:Blood disease|Genetic disease (inborn)
Reference: MedGen: D000755
MeSH: D000755
OMIM: 603903;

Genes: HBB;
Phenotypes
1 HP:0000007Autosomal recessive inheritance
2 HP:0002027Abdominal pain
3 HP:0001640Cardiomegaly
4 HP:0001081Cholelithiasis
5 HP:0000790Hematuria
6 HP:0001878Hemolytic anemia
7 HP:0002240Hepatomegaly
8 HP:0012418Hypoxemia
9 HP:0008346Increased red cell sickling tendency
10 HP:0000952Jaundice
11 HP:0001974Leukocytosis
12 HP:0200023Priapism
13 HP:0002718Recurrent bacterial infections
14 HP:0000083Renal insufficiency
15 HP:0000488Retinopathy
16 HP:0001744Splenomegaly
17 HP:0001297Stroke
Disease Causing ClinVar Variants
Variation_NameGeneIDGeneSymbolClinicalSignificancedbSNPRCVaccessionTestedInGTRPhenotypeIDsChromosomeStartStopHGVS_cHGVS_pHGVS_gOtherIDsDisease_ClinVarDisease_hgmd
NM_000518.4(HBB):c.364G>C (p.Glu122Gln)3043HBBPathogenic;other33946267RCV000016317; RCV000202465; RCV000029994; RCV000016617; RCV000016758; RCV000016858; Y; MedGen:C0002895,OMIM:603903,ORPHA:232,SNOMED CT:127040003; MedGen:C0005283,OMIM:613985,ORPHA:848,SNOMED CT:659590001152469085246908NM_000518.4:c.364G>CNP_000509.1:p.Glu122GlnNC_000011.9:g.5246908C>A,NC_000011.9:g.5246908C>G,NC_000011.9:g.5246908C>THBVAR:509,OMIM Allelic Variant:141900.0065,OMIM Allelic Variant:141900.0276,OMIM Allelic Variant:141900.0407,OMIM Allelic Variant:141900.0502C0005283 613985 beta Thalassemia; C0002895 603903 Hb SS disease
NM_000518.4(HBB):c.364G>C (p.Glu122Gln)3043HBBPathogenic;other33946267RCV000016317; RCV000202465; RCV000029994; RCV000016617; RCV000016758; RCV000016858; Y; MedGen:C0002895,OMIM:603903,ORPHA:232,SNOMED CT:127040003; MedGen:C0005283,OMIM:613985,ORPHA:848,SNOMED CT:659590001152469085246908NM_000518.4:c.364G>CNP_000509.1:p.Glu122GlnNC_000011.9:g.5246908C>A,NC_000011.9:g.5246908C>G,NC_000011.9:g.5246908C>THBVAR:509,OMIM Allelic Variant:141900.0065,OMIM Allelic Variant:141900.0276,OMIM Allelic Variant:141900.0407,OMIM Allelic Variant:141900.0502C0005283 613985 beta Thalassemia; C3841475 Beta-plus-thalassemia; C0002895 603903 Hb SS disease; C0019024 Hemoglobin E; C0472777 Hemoglobin E/beta thalassemia disease; C2720293 Malaria, resistance to
NM_000518.4(HBB):c.364G>C (p.Glu122Gln)3043HBBPathogenic;other33946267RCV000016317; RCV000202465; RCV000029994; RCV000016617; RCV000016758; RCV000016858; Y; MedGen:C0002895,OMIM:603903,ORPHA:232,SNOMED CT:127040003; MedGen:C0005283,OMIM:613985,ORPHA:848,SNOMED CT:659590001152469085246908NM_000518.4:c.364G>CNP_000509.1:p.Glu122GlnNC_000011.9:g.5246908C>A,NC_000011.9:g.5246908C>G,NC_000011.9:g.5246908C>THBVAR:509,OMIM Allelic Variant:141900.0065,OMIM Allelic Variant:141900.0276,OMIM Allelic Variant:141900.0407,OMIM Allelic Variant:141900.0502C0005283 613985 beta Thalassemia; C0002895 603903 Hb SS disease
NM_000518.4(HBB):c.364G>C (p.Glu122Gln)3043HBBPathogenic;other33946267RCV000016317; RCV000202465; RCV000029994; RCV000016617; RCV000016758; RCV000016858; Y; MedGen:C0002895,OMIM:603903,ORPHA:232,SNOMED CT:127040003; MedGen:C0005283,OMIM:613985,ORPHA:848,SNOMED CT:659590001152469085246908NM_000518.4:c.364G>CNP_000509.1:p.Glu122GlnNC_000011.9:g.5246908C>A,NC_000011.9:g.5246908C>G,NC_000011.9:g.5246908C>THBVAR:509,OMIM Allelic Variant:141900.0065,OMIM Allelic Variant:141900.0276,OMIM Allelic Variant:141900.0407,OMIM Allelic Variant:141900.0502C0005283 613985 beta Thalassemia; C0002895 603903 Hb SS disease
NM_000518.4(HBB):c.364G>A (p.Glu122Lys)3043HBBPathogenic;other33946267RCV000016524; RCV000016525; RCV000202511; RCV000029993; RCV000016577; RCV000016863; N; MedGen:C0002895,OMIM:603903,ORPHA:232,SNOMED CT:127040003; MedGen:C0005283,OMIM:613985,ORPHA:848,SNOMED CT:65959000; MedGen:C1264000,SNOMED CT:1270480051152469085246908NM_000518.4:c.364G>ANP_000509.1:p.Glu122LysNC_000011.9:g.5246908C>A,NC_000011.9:g.5246908C>G,NC_000011.9:g.5246908C>THBVAR:510,OMIM Allelic Variant:141900.0202,OMIM Allelic Variant:141900.0245,OMIM Allelic Variant:141900.0507C0005283 613985 beta Thalassemia; C0002895 603903 Hb SS disease; C1264000 Sickle cell-Hemoglobin O Arab disease
NM_000518.4(HBB):c.364G>A (p.Glu122Lys)3043HBBPathogenic;other33946267RCV000016524; RCV000016525; RCV000202511; RCV000029993; RCV000016577; RCV000016863; N; MedGen:C0002895,OMIM:603903,ORPHA:232,SNOMED CT:127040003; MedGen:C0005283,OMIM:613985,ORPHA:848,SNOMED CT:65959000; MedGen:C1264000,SNOMED CT:1270480051152469085246908NM_000518.4:c.364G>ANP_000509.1:p.Glu122LysNC_000011.9:g.5246908C>A,NC_000011.9:g.5246908C>G,NC_000011.9:g.5246908C>THBVAR:510,OMIM Allelic Variant:141900.0202,OMIM Allelic Variant:141900.0245,OMIM Allelic Variant:141900.0507C0005283 613985 beta Thalassemia; C0002895 603903 Hb SS disease; C2720293 Malaria, resistance to; C1264000 Sickle cell-Hemoglobin O Arab disease
NM_000518.4(HBB):c.364G>A (p.Glu122Lys)3043HBBPathogenic;other33946267RCV000016524; RCV000016525; RCV000202511; RCV000029993; RCV000016577; RCV000016863; N; MedGen:C0002895,OMIM:603903,ORPHA:232,SNOMED CT:127040003; MedGen:C0005283,OMIM:613985,ORPHA:848,SNOMED CT:65959000; MedGen:C1264000,SNOMED CT:1270480051152469085246908NM_000518.4:c.364G>ANP_000509.1:p.Glu122LysNC_000011.9:g.5246908C>A,NC_000011.9:g.5246908C>G,NC_000011.9:g.5246908C>THBVAR:510,OMIM Allelic Variant:141900.0202,OMIM Allelic Variant:141900.0245,OMIM Allelic Variant:141900.0507C0005283 613985 beta Thalassemia; C0002895 603903 Hb SS disease; C1264000 Sickle cell-Hemoglobin O Arab disease
NM_000518.4(HBB):c.79G>A (p.Glu27Lys)3043HBBPathogenic;other;protective33950507RCV000016332; RCV000016330; RCV000016329; RCV000016331; RCV000202534; RCV000016617; Y; MedGen:C0002895,OMIM:603903,ORPHA:232,SNOMED CT:127040003; MedGen:C0019024,SNOMED CT:83815000; MedGen:C0472777, Orphanet:ORPHA231249,SNOMED CT: 234392002; MedGen:C2720293; MedGen:C38414751152481735248173NM_000518.4:c.79G>ANP_000509.1:p.Glu27LysNC_000011.9:g.5248173C>TOMIM Allelic Variant:141900.0071,OMIM Allelic Variant:141900.0276C3841475 Beta-plus-thalassemia; C0002895 603903 Hb SS disease; C0019024 Hemoglobin E; C0472777 Hemoglobin E/beta thalassemia disease; C2720293 Malaria, resistance to
NM_000518.4(HBB):c.79G>A (p.Glu27Lys)3043HBBPathogenic;other;protective33950507RCV000016332; RCV000016330; RCV000016329; RCV000016331; RCV000202534; RCV000016617; Y; MedGen:C0002895,OMIM:603903,ORPHA:232,SNOMED CT:127040003; MedGen:C0019024,SNOMED CT:83815000; MedGen:C0472777, Orphanet:ORPHA231249,SNOMED CT: 234392002; MedGen:C2720293; MedGen:C38414751152481735248173NM_000518.4:c.79G>ANP_000509.1:p.Glu27LysNC_000011.9:g.5248173C>TOMIM Allelic Variant:141900.0071,OMIM Allelic Variant:141900.0276C0005283 613985 beta Thalassemia; C3841475 Beta-plus-thalassemia; C0002895 603903 Hb SS disease; C0019024 Hemoglobin E; C0472777 Hemoglobin E/beta thalassemia disease; C2720293 Malaria, resistance to
NM_000518.4(HBB):c.20A>T (p.Glu7Val)3043HBBPathogenic;other;protective334RCV000016286; RCV000030905; RCV000016575; RCV000016573; RCV000016574; RCV000016576; RCV000016577; RCV000016579; RCV000016580; RCV000016877; RCV000016879; Y; MedGen:C0002895,OMIM:603903,ORPHA:232,SNOMED CT:127040003; MedGen:C0019043; MedGen:C1264000,SNOMED CT:127048005; MedGen:C27202931152482325248232NM_000518.4:c.20A>TNP_000509.1:p.Glu7ValNC_000011.9:g.5248232T>A,NC_000011.9:g.5248232T>GOMIM Allelic Variant:141900.0039,OMIM Allelic Variant:141900.0040,OMIM Allelic Variant:141900.0243,OMIM Allelic Variant:141900.0244,OMIM Allelic Variant:C0002895 603903 Hb SS disease; C2720293 Malaria, resistance to; C1264000 Sickle cell-Hemoglobin O Arab disease
NM_000518.4(HBB):c.20A>T (p.Glu7Val)3043HBBPathogenic;other;protective334RCV000016286; RCV000030905; RCV000016575; RCV000016573; RCV000016574; RCV000016576; RCV000016577; RCV000016579; RCV000016580; RCV000016877; RCV000016879; Y; MedGen:C0002895,OMIM:603903,ORPHA:232,SNOMED CT:127040003; MedGen:C0019043; MedGen:C1264000,SNOMED CT:127048005; MedGen:C27202931152482325248232NM_000518.4:c.20A>TNP_000509.1:p.Glu7ValNC_000011.9:g.5248232T>A,NC_000011.9:g.5248232T>GOMIM Allelic Variant:141900.0039,OMIM Allelic Variant:141900.0040,OMIM Allelic Variant:141900.0243,OMIM Allelic Variant:141900.0244,OMIM Allelic Variant:C0002895 603903 Hb SS disease; C0019045 Hemoglobinopathy; C2720293 Malaria, resistance to; C1264000 Sickle cell-Hemoglobin O Arab disease
NM_000518.4(HBB):c.20A>T (p.Glu7Val)3043HBBPathogenic;other;protective334RCV000016286; RCV000030905; RCV000016575; RCV000016573; RCV000016574; RCV000016576; RCV000016577; RCV000016579; RCV000016580; RCV000016877; RCV000016879; Y; MedGen:C0002895,OMIM:603903,ORPHA:232,SNOMED CT:127040003; MedGen:C0019043; MedGen:C1264000,SNOMED CT:127048005; MedGen:C27202931152482325248232NM_000518.4:c.20A>TNP_000509.1:p.Glu7ValNC_000011.9:g.5248232T>A,NC_000011.9:g.5248232T>GOMIM Allelic Variant:141900.0039,OMIM Allelic Variant:141900.0040,OMIM Allelic Variant:141900.0243,OMIM Allelic Variant:141900.0244,OMIM Allelic Variant:C0002895 603903 Hb SS disease; C2720293 Malaria, resistance to; C1264000 Sickle cell-Hemoglobin O Arab disease
NM_000518.4(HBB):c.20A>T (p.Glu7Val)3043HBBPathogenic;other;protective334RCV000016286; RCV000030905; RCV000016575; RCV000016573; RCV000016574; RCV000016576; RCV000016577; RCV000016579; RCV000016580; RCV000016877; RCV000016879; Y; MedGen:C0002895,OMIM:603903,ORPHA:232,SNOMED CT:127040003; MedGen:C0019043; MedGen:C1264000,SNOMED CT:127048005; MedGen:C27202931152482325248232NM_000518.4:c.20A>TNP_000509.1:p.Glu7ValNC_000011.9:g.5248232T>A,NC_000011.9:g.5248232T>GOMIM Allelic Variant:141900.0039,OMIM Allelic Variant:141900.0040,OMIM Allelic Variant:141900.0243,OMIM Allelic Variant:141900.0244,OMIM Allelic Variant:C0002895 603903 Hb SS disease; C2720293 Malaria, resistance to; C1264000 Sickle cell-Hemoglobin O Arab disease
NM_000518.4(HBB):c.20A>T (p.Glu7Val)3043HBBPathogenic;other;protective334RCV000016286; RCV000030905; RCV000016575; RCV000016573; RCV000016574; RCV000016576; RCV000016577; RCV000016579; RCV000016580; RCV000016877; RCV000016879; Y; MedGen:C0002895,OMIM:603903,ORPHA:232,SNOMED CT:127040003; MedGen:C0019043; MedGen:C1264000,SNOMED CT:127048005; MedGen:C27202931152482325248232NM_000518.4:c.20A>TNP_000509.1:p.Glu7ValNC_000011.9:g.5248232T>A,NC_000011.9:g.5248232T>GOMIM Allelic Variant:141900.0039,OMIM Allelic Variant:141900.0040,OMIM Allelic Variant:141900.0243,OMIM Allelic Variant:141900.0244,OMIM Allelic Variant:C0005283 613985 beta Thalassemia; C0002895 603903 Hb SS disease; C2720293 Malaria, resistance to; C1264000 Sickle cell-Hemoglobin O Arab disease
NM_000518.4(HBB):c.20A>T (p.Glu7Val)3043HBBPathogenic;other;protective334RCV000016286; RCV000030905; RCV000016575; RCV000016573; RCV000016574; RCV000016576; RCV000016577; RCV000016579; RCV000016580; RCV000016877; RCV000016879; Y; MedGen:C0002895,OMIM:603903,ORPHA:232,SNOMED CT:127040003; MedGen:C0019043; MedGen:C1264000,SNOMED CT:127048005; MedGen:C27202931152482325248232NM_000518.4:c.20A>TNP_000509.1:p.Glu7ValNC_000011.9:g.5248232T>A,NC_000011.9:g.5248232T>GOMIM Allelic Variant:141900.0039,OMIM Allelic Variant:141900.0040,OMIM Allelic Variant:141900.0243,OMIM Allelic Variant:141900.0244,OMIM Allelic Variant:C0002895 603903 Hb SS disease; C2720293 Malaria, resistance to; C1264000 Sickle cell-Hemoglobin O Arab disease
NM_000518.4(HBB):c.20A>T (p.Glu7Val)3043HBBPathogenic;other;protective334RCV000016286; RCV000030905; RCV000016575; RCV000016573; RCV000016574; RCV000016576; RCV000016577; RCV000016579; RCV000016580; RCV000016877; RCV000016879; Y; MedGen:C0002895,OMIM:603903,ORPHA:232,SNOMED CT:127040003; MedGen:C0019043; MedGen:C1264000,SNOMED CT:127048005; MedGen:C27202931152482325248232NM_000518.4:c.20A>TNP_000509.1:p.Glu7ValNC_000011.9:g.5248232T>A,NC_000011.9:g.5248232T>GOMIM Allelic Variant:141900.0039,OMIM Allelic Variant:141900.0040,OMIM Allelic Variant:141900.0243,OMIM Allelic Variant:141900.0244,OMIM Allelic Variant:C0002895 603903 Hb SS disease; C2720293 Malaria, resistance to; C1264000 Sickle cell-Hemoglobin O Arab disease
NM_000518.4(HBB):c.20A>T (p.Glu7Val)3043HBBPathogenic;other;protective334RCV000016286; RCV000030905; RCV000016575; RCV000016573; RCV000016574; RCV000016576; RCV000016577; RCV000016579; RCV000016580; RCV000016877; RCV000016879; Y; MedGen:C0002895,OMIM:603903,ORPHA:232,SNOMED CT:127040003; MedGen:C0019043; MedGen:C1264000,SNOMED CT:127048005; MedGen:C27202931152482325248232NM_000518.4:c.20A>TNP_000509.1:p.Glu7ValNC_000011.9:g.5248232T>A,NC_000011.9:g.5248232T>GOMIM Allelic Variant:141900.0039,OMIM Allelic Variant:141900.0040,OMIM Allelic Variant:141900.0243,OMIM Allelic Variant:141900.0244,OMIM Allelic Variant:C0002895 603903 Hb SS disease; C2720293 Malaria, resistance to; C1264000 Sickle cell-Hemoglobin O Arab disease
NM_000518.4(HBB):c.20A>T (p.Glu7Val)3043HBBPathogenic;other;protective334RCV000016286; RCV000030905; RCV000016575; RCV000016573; RCV000016574; RCV000016576; RCV000016577; RCV000016579; RCV000016580; RCV000016877; RCV000016879; Y; MedGen:C0002895,OMIM:603903,ORPHA:232,SNOMED CT:127040003; MedGen:C0019043; MedGen:C1264000,SNOMED CT:127048005; MedGen:C27202931152482325248232NM_000518.4:c.20A>TNP_000509.1:p.Glu7ValNC_000011.9:g.5248232T>A,NC_000011.9:g.5248232T>GOMIM Allelic Variant:141900.0039,OMIM Allelic Variant:141900.0040,OMIM Allelic Variant:141900.0243,OMIM Allelic Variant:141900.0244,OMIM Allelic Variant:C0002895 603903 Hb SS disease; C2720293 Malaria, resistance to; C1264000 Sickle cell-Hemoglobin O Arab disease
NM_000518.4(HBB):c.19G>A (p.Glu7Lys)3043HBBPathogenic;other;protective33930165RCV000016251; RCV000016285; RCV000016284; RCV000202507; Y; MedGen:C0002895,OMIM:603903,ORPHA:232,SNOMED CT:127040003; MedGen:C27202931152482335248233NM_000518.4:c.19G>ANP_000509.1:p.Glu7LysNC_000011.9:g.5248233C>G,NC_000011.9:g.5248233C>THBVAR:227,OMIM Allelic Variant:141900.0010,OMIM Allelic Variant:141900.0038C0002895 603903 Hb SS disease; C2720293 Malaria, resistance to
NM_000518.4(HBB):c.19G>A (p.Glu7Lys)3043HBBPathogenic;other;protective33930165RCV000016251; RCV000016285; RCV000016284; RCV000202507; Y; MedGen:C0002895,OMIM:603903,ORPHA:232,SNOMED CT:127040003; MedGen:C27202931152482335248233NM_000518.4:c.19G>ANP_000509.1:p.Glu7LysNC_000011.9:g.5248233C>G,NC_000011.9:g.5248233C>THBVAR:227,OMIM Allelic Variant:141900.0010,OMIM Allelic Variant:141900.0038C0002895 603903 Hb SS disease; C2720293 Malaria, resistance to